Session 9: Beyond Glycemic Control: Promoting Weight Loss Using Glucose-Lowering Medications

Wednesday, July 20, 2022, 12:30 PM - 1:45 PM

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician (1.00 hours)

Date and Time: Session 9: Wednesday, July 20th, 2022 @ 12:30pm-1:45pm PST 
Zoom Webinar ID: 976 0959 8851 
Webinar Link: https://washington.zoom.us/j/97609598851

Talk Title: Beyond Glycemic Control: Promoting Weight Loss Using Glucose-Lowering Medications

To go back to the main course page, please click here.

1. Discuss preferred medications when there is a compelling need to minimize weight gain or promote weight loss
2. Discuss options for combination therapy if A1C is above target
3. Explain which diabetes medication may promote weight gain vs weight loss

After registering, learners can access the OnDemand content available following these steps:

1. Locate "MyCME" on your screen
2. Select "Tests"
3. Locate the preferred session of "OT2207 CardioMetabolic ECHO" and click "Pre-Test" to begin. Additional instructions are contained within each session.
4. In order to receive a certificate, you must complete the evaluation following the post-test.

Accreditation with Commendation: The University of Washington School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation: The University of Washington School of Medicine designates this other activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Each session is worth 1.0 credit. You can participate in the live, enduring material and/or both. You can only claim credit once per session (live vs recorded).  In order to receive credit, learners must attend the live webinar OR watch the recorded content.  For webinar recordings, learners must answer pre/post test questions with a 70% pass rate to receive credit.  All learners must complete the post-session assessment to claim credit.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 24 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the University of Washington School of Medicine’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ACPE Accreditation

The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. Each session is worth 1.0 CPE. To receive credit you must complete the post-session evaluation for each session you attend. At the conclusion of the series, participants should be able to combat clinical and medication inertia around cardiometabolic therapy.

ACPE activity number: 0130-9999-22-348-H01-P; 0130-9999-22-348-L01-P

Laura Montour, MD, is a dual-board certified family physician in both Canada and the USA. She is a Fellow of the American Academy of Family Physicians and she is also a Certified Diplomate of the American Board of Obesity Medicine. She has been a family doctor for almost 13 years, and she is currently a Clinical Assistant Professor in the Department of Family Medicine at the University of Washington. She sees patients at the University of Washington Center for Weight Loss and Metabolic Surgery. Her clinical interests include medical weight management and care of bariatric surgical patients.

Dr. Montour is a member of the American Academy of Metabolic and Bariatric Surgery (ASMBS), and she serves on the ASMBS Washington State Chapter as a member-at-large. She is also a member of the Early Career Committee with The Obesity Society and she serves on the Bariatric Medical-Surgical Committee with the Obesity Medicine Association. Dr. Montour is a First Nations Mohawk woman from the Six Nations Reserve. Growing up in Canada on the Six Nations reserve she has witnessed the impacts of Obesity and Diabetes within her community. It is through these personal experiences that Dr. Montour has now dedicated her career to the prevention and treatment of the disease of Obesity and its comorbidities.

Speaker Disclosures: Laura Montour, MD: No Disclosures

Planner Disclosure(s):

• Nicole Ehrhardt, MD is on the Advisory Board for Dexcom and NovoNordisk; Education Grant from NovoNordisk and Merck; Investigator with Dexcom
• Savitha Subramanian, MD is on the Advisory Board for Abbott Diabetes Care; former Advisory Board for Akcea Therapeutics and Amarni
• Lorena Casas-Wright, MD: No Disclosures
  
• Nayan Arora, MD: No Disclosures

All relevant financial relationships have been mitigated.

Mitigation of Relevant Financial Relationships

University of Washington School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Wednesday, July 20, 2022

We would like to thank NovoNordisk for providing an unrestricted educational grant to support the Cardiometabolic ECHO Program.